"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
| Descriptor ID |
D004345
|
| MeSH Number(s) |
J01.576.655.750
|
| Concept/Terms |
Drug Industry- Drug Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
- Pharmaceutical Industry
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in this website by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 4 | 5 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 3 | 1 | 4 |
| 2015 | 1 | 2 | 3 |
| 2016 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles.
-
Schaefer G, Balchunas J, Charlebois T, Erickson J, Hart R, Kedia SB, Lee KH. Driving adoption of new technologies in biopharmaceutical manufacturing. Biotechnol Bioeng. 2023 09; 120(9):2765-2770.
-
Sridhar J. Current Digital Direct-to-Consumer Advertising-The Tip of the Iceberg. JAMA Ophthalmol. 2022 06 01; 140(6):642-643.
-
Watane A, Kalavar M, Reyes J, Yannuzzi NA, Sridhar J. The Effect of Market Competition on the Price of Topical Eye Drops. Semin Ophthalmol. 2022 Jan 02; 37(1):42-48.
-
Khanal O, Lenhoff AM. Developments and opportunities in continuous biopharmaceutical manufacturing. MAbs. 2021 Jan-Dec; 13(1):1903664.
-
Snyder CM, Hoyt K, Gouglas D, Johnston T, Robinson J. Designing Pull Funding For A COVID-19 Vaccine. Health Aff (Millwood). 2020 Sep; 39(9):1633-1642.
-
Lee KH, Mantle JL. Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting. PDA J Pharm Sci Technol. 2021 Jan-Feb; 75(1):48-63.
-
Mantle JL, Lee KH. NIIMBL-Facilitated Active Listening Meeting between Industry and FDA Identifies Common Challenges for Adoption of New Biopharmaceutical Manufacturing Technologies. PDA J Pharm Sci Technol. 2020 Sep-Oct; 74(5):497-508.
-
Wang JV, Chapman LW, Keller M, Zachary CB. Experiences of Dermatologic Surgeons With the Sunshine Act: A National Survey. Dermatol Surg. 2019 06; 45(6):864-867.
-
Niforatos JD, Pescatore RM. Financial relationships with industry among guideline authors for the management of acute ischemic stroke. Am J Emerg Med. 2019 05; 37(5):921-923.
-
Tollman P, Panier V, Dosik D, Biondi P, Cuss F. Organizational effectiveness: a key to R&D productivity. Nat Rev Drug Discov. 2016 07; 15(7):441-2.